Endovia Health Sciences (EDVA) Current Leases (2019 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Current Leases (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | - |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 37,052.00 |
| Dec 31, 2025 | 50,720.00 |
| Sep 30, 2025 | 120,942.00 |
| Jun 30, 2025 | 190,224.00 |
| Mar 31, 2025 | 249,456.00 |
| Dec 31, 2024 | 58,840.00 |
| Sep 30, 2024 | 274,574.00 |
| Jun 30, 2024 | 270,606.00 |
| Mar 31, 2024 | 266,704.00 |
| Dec 31, 2023 | 262,860.00 |
| Sep 30, 2023 | 259,072.00 |
| Jun 30, 2023 | 230,945.00 |
| Mar 31, 2023 | 250,734.00 |
| Dec 31, 2022 | 268,749.00 |
| Sep 30, 2022 | 290,789.00 |
| Jun 30, 2022 | 287,885.00 |
| Mar 31, 2022 | 284,372.00 |
| Dec 31, 2021 | 294,067.00 |
| Sep 30, 2021 | 313,982.00 |
| Jun 30, 2021 | 320,662.00 |